Published in Microbiology on August 01, 1999
Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin. PLoS Pathog (2009) 1.47
Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J Virol (2001) 1.25
Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother (2012) 1.18
Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus. J Virol (2006) 1.15
Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One (2009) 1.05
Inactivation and purification of cowpea mosaic virus-like particles displaying peptide antigens from Bacillus anthracis. J Virol Methods (2007) 0.81
Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants. Vaccines (Basel) (2015) 0.79
Can plant viruses cross the kingdom border and be pathogenic to humans? Viruses (2015) 0.79
Virus-Based Nanoparticles as Versatile Nanomachines. Annu Rev Virol (2015) 0.78
Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs). PLoS One (2008) 0.78
The genetical evolution of social behaviour. I. J Theor Biol (1964) 46.36
The evolution of cooperation. Science (1981) 32.89
The genetical evolution of social behaviour. II. J Theor Biol (1964) 28.07
Heritable true fitness and bright birds: a role for parasites? Science (1982) 14.32
Extraordinary sex ratios. A sex-ratio theory for sex linkage and inbreeding has new implications in cytogenetics and entomology. Science (1967) 13.83
The moulding of senescence by natural selection. J Theor Biol (1966) 11.30
Geometry for the selfish herd. J Theor Biol (1971) 10.91
Selfish and spiteful behaviour in an evolutionary model. Nature (1970) 4.65
Evolutionarily stable dispersal strategies. J Theor Biol (1980) 4.11
Characterization of a protein-lipopolysaccharide complex released from cell walls of Pseudomonas aeruginosa by ethylenediaminetetraacetic acid. Can J Microbiol (1969) 3.22
Ultrastructural and chemical alteration of the cell envelope of Pseudomonas aeruginosa, associated with resistance to ethylenediaminetetraacetate resulting from growth in a Mg2+-deficient medium. J Bacteriol (1974) 2.50
Electron paramagnetic resonance of nitrogenase and nitrogenase components from Clostridium pasteurianum W5 and Azotobacter vinelandii OP. Proc Natl Acad Sci U S A (1972) 2.24
Demonstration of the bipartite nature of the genome of a single-stranded DNA plant virus by infection with the cloned DNA components. Nucleic Acids Res (1983) 2.24
The Rhizobium nodulation gene nodO encodes a Ca2(+)-binding protein that is exported without N-terminal cleavage and is homologous to haemolysin and related proteins. EMBO J (1990) 2.15
Antibiotics cause parthenogenetic Trichogramma (Hymenoptera/Trichogrammatidae) to revert to sex. Proc Natl Acad Sci U S A (1990) 2.08
Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa. J Bacteriol (1976) 2.06
Freeze-etch study of Pseudomonas aeruginosa: localization within the cell wall of an ethylenediaminetetraacetate-extractable. J Bacteriol (1973) 1.87
Regulatory mutants of polyoma virus defective in DNA replication and the synthesis of early proteins. Cell (1980) 1.85
Sex against virulence: the coevolution of parasitic diseases. Trends Ecol Evol (1996) 1.84
Chemical alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates. J Bacteriol (1979) 1.81
Identification of novel DNA forms in tomato golden mosaic virus infected tissue. Evidence for a two component viral genome. Nucleic Acids Res (1982) 1.80
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res (1993) 1.77
Molecular cloning and characterisation of the two DNA components of tomato golden mosaic virus. Nucleic Acids Res (1982) 1.77
Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun (1984) 1.75
Starch branching enzymes belonging to distinct enzyme families are differentially expressed during pea embryo development. Plant J (1995) 1.68
Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63
Proteins released from cell envelopes of Pseudomonas aeruginosa on exposure to ethylenediaminetetraacetate: comparison with dimethylformamide-extractable proteins. J Bacteriol (1973) 1.63
Viable deletion mutant in the medium and large T-antigen-coding sequences of the polyoma virus genome. J Virol (1980) 1.60
Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J Infect Dis (1987) 1.43
Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Infect Immun (1992) 1.42
1959 Manchester case of syndrome resembling AIDS. Lancet (1996) 1.40
The nucleotide sequence of cloned wheat dwarf virus DNA. EMBO J (1985) 1.34
Persistence and expression of histone genes injected into Xenopus eggs in early development. Nature (1981) 1.34
Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression. Virology (1985) 1.33
Regulation of equine herpesvirus type 1 gene expression: characterization of immediate early, early, and late transcription. Virology (1987) 1.33
The organisation and interviral homologies of genes at the 3' end of tobacco rattle virus RNA1. EMBO J (1986) 1.30
Plant-derived vaccine protects target animals against a viral disease. Nat Biotechnol (1997) 1.27
Characterization and mapping of equine herpesvirus type 1 immediate early, early, and late transcripts. Virus Res (1987) 1.23
Single and multiple mutations affecting properties of the regulatory gene nodD of Rhizobium. Mol Microbiol (1989) 1.19
Humanization of a mouse monoclonal antibody by CDR-grafting: the importance of framework residues on loop conformation. Protein Eng (1991) 1.18
Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. Gastroenterology (1992) 1.18
Demonstration of cell division by septation in a variety of gram-negative rods. J Bacteriol (1975) 1.16
Molecular characterization of the nodulation gene, nodT, from two biovars of Rhizobium leguminosarum. Mol Microbiol (1990) 1.15
Adaptive resistance to polymyxin in Pseudomonas aeruginosa due to an outer membrane impermeability mechanism. Can J Microbiol (1982) 1.14
Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun (1988) 1.14
Lipid alterations in cell envelopes of polymyxin-resistant Pseudomonas aeruginosa isolates. J Bacteriol (1981) 1.13
Fidelity of transcription of Xenopus laevis globin genes injected into Xenopus laevis oocytes and unfertilized eggs. Mol Cell Biol (1984) 1.07
Deletion mutants of polyoma virus defining a nonessential region between the origin of replication and the initiation codon for early proteins. J Virol (1979) 1.06
Optimization of primers for cloning libraries of mouse immunoglobulin genes using the polymerase chain reaction. Eur J Immunol (1993) 1.05
Cowpea mosaic virus as a vaccine carrier of heterologous antigens. Mol Biotechnol (2001) 1.05
Rapid PCR-cloning of full-length mouse immunoglobulin variable regions. Biotechnology (N Y) (1991) 1.04
Adaptive resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa. J Med Microbiol (1989) 1.04
Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers. Infect Immun (1999) 1.03
Differential expression of the Xenopus laevis tadpole and adult beta-globin genes when injected into fertilized Xenopus laevis eggs. Mol Cell Biol (1984) 1.03
Analysis of the in vitro translation products of the equine herpesvirus type 1 immediate early mRNA. Virology (1988) 1.02
A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun (1998) 1.02
Replication and expression of Xenopus laevis globin genes injected into fertilized Xenopus eggs. Proc Natl Acad Sci U S A (1983) 1.01
Humanization of a mouse antibody against human alpha-4 integrin: a potential therapeutic for the treatment of multiple sclerosis. Hum Antibodies (1997) 1.00
Genetic algorithms and evolution. J Theor Biol (1990) 0.99
Viral transcripts in cells infected with defective interfering particles of equine herpesvirus type 1. Virology (1989) 0.99
Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific. Infect Immun (1995) 0.97
Chemical alterations in cell envelopes of polymyxin-resistant mutants of Pseudomonas aeruginosa grown in the absence or presence of polymyxin. Antimicrob Agents Chemother (1982) 0.97
Structure and genetic complexity of the genomes of herpesvirus defective-interfering particles associated with oncogenic transformation and persistent infection. J Virol (1984) 0.96
Clone mixtures and a pacemaker: new facets of Red-Queen theory and ecology. Proc Biol Sci (2002) 0.96
Vaccine efficacies of elastase, exotoxin A, and outer-membrane protein F in preventing chronic pulmonary infection by Pseudomonas aeruginosa in a rat model. J Med Microbiol (1993) 0.95
Conversion of phospholipids to free fatty acids in response to acquisition of polymyxin resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1983) 0.95
Equine herpesvirus type 1 defective-interfering (DI) particle DNA structure: the central region of the inverted repeat is deleted from DI DNA. Virology (1987) 0.95
Transcription of sea urchin histone genes in HeLa cells. Nucleic Acids Res (1983) 0.93
Structure of the genome of equine herpesvirus type 3. Virology (1984) 0.92
Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. FEMS Immunol Med Microbiol (2000) 0.90
Cloning and fine mapping the DNA of equine herpesvirus type one defective interfering particles. Virology (1986) 0.90
Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus. Microbiology (1999) 0.90
Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. Vaccine (2002) 0.89
The play by nature. Science (1977) 0.89
Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. J Virol (1999) 0.89
Ultrastructure of the cell wall and the mechanism of cellular division of a gram-variable coccus. Can J Microbiol (1971) 0.88
Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P. aeruginosa. Infect Immun (2001) 0.88
Characterization of transduction by bacteriophage T1: time of production and density of transducing particles. J Virol (1975) 0.87
Preservation of pulmonary function by an outer membrane protein F vaccine. A study in rats with chronic pulmonary infection caused by Pseudomonas aeruginosa. Chest (1994) 0.86
Polyoma viruses with mutations at endonuclease HindII site 1: alterations at the COOH terminus of VP1. J Virol (1979) 0.86
Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus. Vaccine (2001) 0.86
Genetic relatedness and colinearity of genomes of equine herpesvirus types 1 and 3. J Virol (1986) 0.86
Kinetics of appearance and disappearance of light-induced EPR signals of P700+ and iron-sulfur proteins(s) at low temperature. Biochim Biophys Acta (1974) 0.86
Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa. Curr Microbiol (1995) 0.85